Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-21
2007-08-21
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000
Reexamination Certificate
active
10788996
ABSTRACT:
Provided herein are novel compounds of formula I below:in which the radicals are as defined, their physiologically acceptable salts, processes for their preparation, as well as methods of treating and/or preventing disorders of disorders of fatty acid metabolism and glucose utilization disorders, and also of disorders in which insulin resistance is involved, in a patient.
REFERENCES:
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6277831 (2001-08-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch et al.
patent: 6506757 (2003-01-01), Tajima et al.
patent: 7148246 (2006-12-01), Gretzke et al.
patent: 1 067 109 (2001-01-01), None
patent: 1 108 713 (2001-06-01), None
patent: 0 462 884 (2001-12-01), None
patent: 1 354 879 (2003-10-01), None
patent: WO94/18183 (1994-08-01), None
patent: WO94/18184 (1994-08-01), None
patent: WO96/38428 (1996-12-01), None
patent: WO97/26265 (1997-07-01), None
patent: WO97/41097 (1997-11-01), None
patent: WO98/08871 (1998-03-01), None
patent: WO98/19998 (1998-05-01), None
patent: WO99/03861 (1999-01-01), None
patent: WO99/15525 (1999-04-01), None
patent: WO99/61431 (1999-12-01), None
patent: WO99/62871 (1999-12-01), None
patent: WO99/62872 (1999-12-01), None
patent: WO99/67278 (1999-12-01), None
patent: WO99/67279 (1999-12-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/04146 (2001-01-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/21602 (2001-03-01), None
patent: WO 01/40169 (2001-06-01), None
patent: WO 01/40171 (2001-06-01), None
patent: WO 01/72290 (2001-10-01), None
patent: WO 01/81327 (2001-11-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 01/94300 (2001-12-01), None
patent: WO 02/16331 (2002-02-01), None
patent: WO 02/38541 (2002-05-01), None
patent: WO 02/50027 (2002-06-01), None
patent: WO 02/051820 (2002-07-01), None
patent: WO 02/096864 (2002-12-01), None
patent: WO 03/020269 (2003-03-01), None
patent: WO 03/040174 (2003-05-01), None
patent: WO 03/084922 (2003-10-01), None
patent: WO 03/084923 (2003-10-01), None
patent: WO 03/104188 (2003-12-01), None
Asakawa A et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Research; vol. 33(9); 2001; pp. 554-558.
Berger Joel et al., The Mechanisms of Action of PPARs, Annul. Rev. Med.; vol. 53; 2002; pp. 409-435.
Fruchart Jean-Charles et al., PPARs, Metabolic Disease and Atherosclerosis, Pharmacological Research; vol. 44, No. 5; 2001; pp. 345-352.
Kersten Sander et al et al., Roles of PPARs in Health and Disease, Nature; vol. 405; May 25, 2000; pp. 421-424.
Kliewer Steven A et al., Peroxisome Proliferator-Activated Receptors: From Genes to Physiology, Recent Prog. Horm Res.; vol. 56; 2001; pp. 239-263.
Lee Daniel W et al., Leptin agonists as a potential approach to the treatment of obesity, Drugs of the Future; vol. 26(9); 2001; pp. 873-881.
Motojima Kiyoto, Peroxisome Proliferator-Activated Receptor (PPAR): Structure, Mechanisms of Activation and Diverse Functions, Cell Structure and Function; vol. 18; 1993; pp. 267-277.
Okada Hiroshi et al., Synthesis and Antitumor Activities of Prodrugs of Benzoylphenylureas, Chem. Pharm. Bull.; vol. 42(1); 1994; pp. 57-61.
Pineda Torra Ines et al., Peroxisome Proliferator-activated Receptors: from Transcriptional Control to Clinical Practice, Curr. Opin. Lipidol; vol. 12; 2001; pp. 245-254.
Pineda Torra Ines et al., Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging, Curr. Opin. Lipidol; vol. 10; 1999; pp. 151-159.
Vidal-Puig A et al., Regulation of PPAR y Gene Expression by Nutrition and Obesity in Rodents, J. Clin. Invest.; vol. 97, No. 11, 1996; pp. 2553-2561.
Wilson Timothy M. et al., The PPARs: From Orphan Receptors to Drug Discovery, Journal of Medicinal Chemistry; vol. 43, No. 4; 2000; pp. 527-550.
Zunft H., J. F. et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in Natural Therapy; vol. 18, No. 5; Sep.-Oct. 2001; pp. 230-236.
Falk Eugen
Glombik Heiner
Goerlitzer Jochen
Gretzke Dirk
Keil Stefanie
Bell Craig M.
Saeed Kamal A.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Cycloalkylmethoxy-substituted acetic acid derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkylmethoxy-substituted acetic acid derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkylmethoxy-substituted acetic acid derivatives,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3852199